18 results
DEF 14A
SYRA
Syra Health Corp - Ordinary Shares
24 Apr 24
Definitive proxy
5:01pm
his retirement in December 2017. Moreover, Dr. Dahlem has served in various other capacities at Eli Lilly and Company including Vice President
10-K
2023 FY
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Annual report
3:01pm
of Accrued Expenses
December 31,
Accrued payroll and taxes
Accrued expenses
Accrued retirement contributions
Accrued franchise taxes
Accrued interest
Total … $88,327 of investment retirement account contribution expenses pursuant to the Company’s matching contributions, including $8,778, as accrued
10-K
2023 FY
EX-97.1
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Annual report
3:01pm
to the exchange or association); or (C) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly
10-Q
2023 Q3
SYRA
Syra Health Corp - Ordinary Shares
14 Nov 23
Quarterly report
12:00pm
, consisted of the following:
Schedule of Accrued Expenses
September 30,
December 31,
Accrued payroll and taxes
Accrued retirement contributions
8-K
SYRA
Syra Health Corp - Ordinary Shares
4 Oct 23
Syra Health Corp. Announces Pricing of Upsized Initial Public Offering
4:45pm
and Chief Operating Officer of Lilly Research Laboratories and Lilly Research Laboratories Europe at Eli Lilly and Company until his retirement
424B4
zpv3 7du1fr9tu
3 Oct 23
Prospectus supplement with pricing info
6:10am
S-1/A
812m v4fp7mc3cwcvkx
12 Jun 23
IPO registration (amended)
9:05pm
S-1/A
EX-10.16
c0am9ag9vz3t0
12 Jun 23
IPO registration (amended)
9:05pm
S-1
EX-10.5
d8a1r6wg39gg99ho
3 May 23
IPO registration
9:34pm
S-1
ntw6nswm lhati4n
3 May 23
IPO registration
9:34pm
S-1
EX-10.17
aqqn0s16or zsv8m
3 May 23
IPO registration
9:34pm
- Prev
- 1
- Next